# Reirradiation With Concurrent Paclitaxel for Breast Cancer

> **NCT02058667** · PHASE1 · WITHDRAWN · sponsor: **University of Kentucky**

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** Paclitaxel+Initial Radiation+Boost

## Key facts

- **NCT ID:** NCT02058667
- **Lead sponsor:** University of Kentucky
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-07
- **Primary completion:** 2015-12
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2016-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02058667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02058667, "Reirradiation With Concurrent Paclitaxel for Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02058667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*